8-K - Tvardi Therapeutics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Tvardi Therapeutics, Inc. has set June 9, 2026 as the date for its 2026 Annual Meeting of Stockholders. The filing specifies deadlines for stockholder proposals under Rule 14a-8 (March 16, 2026), advance notice bylaws (March 16, 2026), and Rule 14a-19 universal proxy notices (April 10, 2026).

Key Takeaways

12026 Annual Meeting date: June 9, 2026

2Rule 14a-8 stockholder proposals deadline: March 16, 2026

3Bylaws advance notice deadline for nominations/other matters: March 16, 2026

4Rule 14a-19 universal proxy notice deadline: April 10, 2026

5Proposals after deadlines may allow discretionary proxy voting

Current Report Details

Event Type

Other Event

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events. Tvardi Therapeutics, Inc. (the “Company”) has set June 9, 2026 as the date for the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annu

Other Event

Exhibits (1)

8-K

FORM 8-K